跳至主要内容
临床试验/CTRI/2019/09/021152
CTRI/2019/09/021152已完成3 期

Randomized Controlled Trial to compare two different doses of Folinic acid (leucovorin) in Methotrexate Toxicity - FLIMT

PGIMER Chandigarh0 个研究点目标入组 38 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 A patient prescribed weekly or the biweekly dose of tablet or parenteral Methotrexate (up to 50 mg per week) for rheumatic or dermatologic or gastrointestinal disease
  • 2 Patient having methotrexate hematologic Toxicity defined as EITHER WBC less than 2000 AND OR Platelet count less than 50000 per microlitre (with or without mucositis)
  • 3 Either inadvertent overdose OR renal dysfunction

排除标准

  • 1 Patient not consenting for the study
  • 2 Patient being treated with High Dose Methotrexate regimen.
  • 3 Patient <12 years of age
  • 4 Patient already received more than one dose of folinic acid

研究者

相似试验

To Compare benefit of two doses of a drug folinic... | 临床试验